Stay up to date with the latest news about our innovation initiatives

Published on 25/05/2023

New models for non-melanoma skin cancer

Almirall and the Centre for Genomic Regulation (CRG) collaborate to develop and characterize novel preclinical models for non-melanoma skin cancer

Published on 28/11/2022

Almirall joins IMI project FACILITATE

We participate in FACILITATE, a patient-driven Innovative Medicines Initiative (IMI) project to enable the use of clinical trial data by study participants.

Published on 20/07/2022

AlmirallShare 7th call is out now!

AlmirallShare new call is seeking new partenship opportunities for preclinical and clinical stage assets that can become new treatments for skin diseases

Published on 20/05/2022

Innovative therapies for vitiligo

Almirall and Inserm Transfert enter into a licensing and research collaboration to develop innovative treatments for vitiligo